760 results on '"Paulus, Walter J."'
Search Results
2. Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
3. Heart failure with preserved ejection fraction
4. Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases.
5. Geranylgeranylacetone reduces cardiomyocyte stiffness and attenuates diastolic dysfunction in a rat model of cardiometabolic syndrome
6. Paving the Road for Interleukin-6 Inhibition in Heart Failure With Preserved Ejection Fraction
7. Diastolic dysfunction is initiated by cardiomyocyte impairment ahead of endothelial dysfunction due to increased oxidative stress and inflammation in an experimental prediabetes model
8. Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin
9. Nitric Oxide and Cardiac Contraction: Clinical Studies
10. Alterations in Ventricular Function
11. Contributors
12. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction
13. Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling
14. Sex differences in circulating proteins in heart failure with preserved ejection fraction
15. Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction
16. Effects of tDCS on motor learning and memory formation: A consensus and critical position paper
17. p47phox-Dependent Reactive Oxygen Species Stimulate Nuclear Translocation of the FoxO1 Transcription Factor During Metabolic Inhibition in Cardiomyoblasts
18. Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
19. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
20. Ventricular myocarditis coincides with atrial myocarditis in patients
21. Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles
22. Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure With Preserved Ejection Fraction?
23. Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction
24. Phenotypic Persistence in Heart Failure With Preserved Ejection Fraction
25. Atrial Fibrillation Coincides with the Advanced Glycation End Product Nε-(Carboxymethyl)Lysine in the Atrium
26. Ultrasound and Microbubble-Induced Local Delivery of MicroRNA-Based Therapeutics
27. Heart failure with preserved ejection fraction: a nephrologist-directed primer
28. Low-grade inflammation and endothelial dysfunction explain the association between retinopathy and left ventricular ejection fraction in men: an 8-year follow-up of the Hoorn Study
29. H2FPEF Score: At Last, a Properly Validated Diagnostic Algorithm for Heart Failure With Preserved Ejection Fraction
30. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology
31. Coronary Artery Disease and Diastolic Left Ventricular Dysfunction
32. Invasive Evaluation of Diastolic Left Ventricular Dysfunction
33. Abstract 14800: Limited Accuracy of the New ASE/EACVI-Algorithm for Heart Failure With Preserved Ejection Fraction (VeeDIA-Study I)
34. Border Disputes Between Heart Failure Phenotypes
35. Myocardial Contractile Effects of Nitric Oxide
36. A Novel Paradigm for Heart Failure With Preserved Ejection Fraction: Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
37. The Role of Nitric Oxide in the Failing Heart
38. α-B Crystallin Reverses High Diastolic Stiffness of Failing Human Cardiomyocytes
39. Phosphodiesterase‐5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention
40. Increased cardiovascular risk 9-16 years after early onset preeclampsia: 67
41. Higher prevalence of diastolic dysfunction in women who have had a decade ago early onset preeclampsia: 66
42. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
43. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life
44. Intracoronary pressure measurements with a 0.015″ fluid-filled angioplasty guide wire
45. Comparative Effects of Ischemia and Hypoxemia on Left Ventricular Diastolic Function in Humans
46. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap
47. From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress
48. Failure of myocardial inactivation: a clinical assessment in the hypertrophied heart
49. From hemodynamic principles to clinical management
50. FROM SYSTEMIC INFLAMMATION TO MYOCARDIAL FIBROSIS: THE HFPEF PARADIGM REVISITED
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.